The Indiana Biosciences Research Institute in Indianapolis is bringing together several big industry names for a major study on how type 2 diabetes varies in different patients. Inside INdiana Business talks to Chief Executive Officer David Broecker about what he calls a "first-of-its-kind" partnership that involves Eli Lilly and Co., Roche Diagnostics Corp., the Regenstrief Institute and the Indiana University School of Medicine. 

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}